Bonus Episode: IAS 2023 Conference HighlightsDr. William Short and Dr. Laura Armas-Kolostroubis join Bruce to talk about the research coming out of the 12th IAS Conference on HIV Science that took place July 23-26, 2023. They discuss some of the groundbreaking studies presented at the conference and how the research can be translated into clinical practice. They talk about research on zero transmission, studies looking at the next steps in long-acting technologies, and findings from a clinical trial on the use of statins to prevent cardiovascular disease for those with HIV. They also explore the latest on doxycycline PEP for STI prevention and highlight findings from the ANCHOR study on anal cancer and how to prevent it in people with HIV. About Dr. Short and Dr. Armas-Kolostroubis William R. Short, MD, MPH, AAHIVS, is an Associate Professor of Medicine at the Perelman School of Medicine at the University of Pennsylvania. He is also associate director of the HIV Clinical Trial Unit at the University of Pennsylvania and the co-director of the Clinical Core for the Penn Center for AIDS Research. He is chair of the board of directors of the American Academy of HIV Medicine.Laura Armas-Kolostroubis, MD, FACP, AAHIVS, is the founder and CEO of Human Centered Consulting and Care. In clinical practice for more than 20 years, Dr. Armas-Kolostroubis was a practicing physician and Chief Medical Officer at CAN Community Health, and she was a clinical director for the Texas/Oklahoma AIDS Education and Training Center. She sits on the board of directors for the American Academy of HIV Medicine. Resources:IAS 2023, the 12th IAS Conference on HIV Science - https://www.iasociety.org/conferences/ias2023ANCHOR Study - https://anchorstudy.org/REPREIVE Trial - https://www.reprievetrial.org/ ******** Questions about this topic? E-mail [email protected] to get connected with Bruce or any of our guests. Are you a medical provider and want to join the conversation? Make your voice heard in the Academy Communities and connect with other HIV clinicians! To learn more about the Academy, visit www.aahivm.org

Dr. Donna Sweet and Bruce discuss the history of the HIV epidemic through the lens of Dr. Sweet’s personal experience as a practitioner. They talk about the early experiences of treating and managing HIV and AIDS before tests, empirical treatments, and sufficient knowledge about the virus. They discuss how antiretroviral therapy and new clinical case definitions in the 1990s and 2000s allowed for better treatment and management of HIV. Throughout the conversation, they mention how the stigma surrounding HIV and homosexuality remains prevalent and unnecessary and the danger of continuing misinformation. They conclude with an outlook on the future of HIV medicine, vaccinations and cure.  About Dr. Donna Sweet:Donna Sweet, MD, AAHIVS, MACP, is a professor of internal medicine at the University of Kansas School of Medicine in Wichita, Kansas, and has been credentialed with the Academy since its inception. She has an HIV program in her clinic with federal Ryan White, Parts B, C, D and F funds, where she cares for approximately 1,400 patients with HIV. Resources: Timeline of the HIV epidemic - https://www.hiv.gov/hiv-basics/overview/history/hiv-and-aids-timeline  UCSF AIDS History Project Collections - https://www.library.ucsf.edu/archives/aids/collections/ Future directions - https://www.niaid.nih.gov/diseases-conditions/future-hiv-treatment  ******** Questions about this topic? E-mail [email protected] to get connected with Bruce or any of our guests. Are you a medical provider and want to join the conversation? Make your voice heard in the Academy Communities and connect with other HIV clinicians! To learn more about the Academy, visit www.aahivm.org